Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Dazdotuftide by Tarsier Pharma for Glaucoma: Likelihood of Approval
Dazdotuftide is under clinical development by Tarsier Pharma and currently in Phase III for Glaucoma. According to GlobalData, Phase III...
Data Insights
Dazdotuftide by Tarsier Pharma for Anterior Uveitis: Likelihood of Approval
Dazdotuftide is under clinical development by Tarsier Pharma and currently in Phase III for Anterior Uveitis. According to GlobalData, Phase...